Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
New York Appeals Court Upholds Dismissal of Mirena MDL
The U.S. Court of Appeals for the Second Circuit has upheld the summary judgment dismissal of the multidistrict lawsuit (MDL) against the maker of the intrauterine birth control device Mirena after finding that none of the experts proffered by the nearly 1,300 plaintiffs were reliable. Mirena MDL v. Bayer Healthcare Pharmaceuticals Inc., 2017 U.S. App. LEXIS 20875 (2nd Cir. 10/24/17).
Plaintiffs all claimed they were injured by the implantable intrauterine birth control device marketed by Bayer under the name Mirena. All parties agreed that it was possible for a user's uterus to be injured during the insertion of the device, but the plaintiffs claimed that their injuries did not occur at insertion but later on, because the device migrated and perforated their uteri.
The plaintiffs presented three expert witnesses to back up their claims that the device migrated after insertion, but the U.S. District Court for the Southern District of New York found all three unreliable. Specifically, District Court Judge Cathy Siebel found that none of the experts had done any research on the question of Mirena device migration prior to being hired by the plaintiffs, and all assumed that the women's explanation of the cause of their injuries was valid. According to Judge Siebel, the plaintiffs' experts accepted this explanation, then “worked backwards to hypothesize a mechanism by which it might occur.”
The Second Circuit panel, made up of Judges John Walker Jr., Jose Cabranes and Reena Raggi, affirmed after finding that the expert testimony offered did not meet the test for admissibility found in Daubert v. Merrell Dow Pharmaceuticals. One of the criteria in Daubert — that the expert's theory is one that had been accepted by the relevant scientific community — seemed particularly troubling to the appeals court, as it was shown that the obstetrics and gynecological community has not accepted that the “secondary perforation” the plaintiffs claimed is something that actually occurs. On this point, the court concluded that “[n]ot only do the experts fail to identify any authorities that directly support the existence of secondary perforation, but what scientific authority there is casts doubt on the phenomenon's existence.”
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
What Law Firms Need to Know Before Trusting AI Systems with Confidential Information In a profession where confidentiality is paramount, failing to address AI security concerns could have disastrous consequences. It is vital that law firms and those in related industries ask the right questions about AI security to protect their clients and their reputation.
GenAI's ability to produce highly sophisticated and convincing content at a fraction of the previous cost has raised fears that it could amplify misinformation. The dissemination of fake audio, images and text could reshape how voters perceive candidates and parties. Businesses, too, face challenges in managing their reputations and navigating this new terrain of manipulated content.
During the COVID-19 pandemic, some tenants were able to negotiate termination agreements with their landlords. But even though a landlord may agree to terminate a lease to regain control of a defaulting tenant's space without costly and lengthy litigation, typically a defaulting tenant that otherwise has no contractual right to terminate its lease will be in a much weaker bargaining position with respect to the conditions for termination.
As the relationship between in-house and outside counsel continues to evolve, lawyers must continue to foster a client-first mindset, offer business-focused solutions, and embrace technology that helps deliver work faster and more efficiently.
The International Trade Commission is empowered to block the importation into the United States of products that infringe U.S. intellectual property rights, In the past, the ITC generally instituted investigations without questioning the importation allegations in the complaint, however in several recent cases, the ITC declined to institute an investigation as to certain proposed respondents due to inadequate pleading of importation.